Skip to main content

FormFactor Expands Silicon Photonics Test Capabilities With Acquisition of Keystone Photonics

LIVERMORE, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) — FormFactor, Inc. (NASDAQ: FORM), a leading semiconductor test and measurement supplier, announced today the acquisition of Keystone Photonics, a pioneer in optical probing technology for silicon photonics (SiPh) and co-packaged optics (CPO) wafer testing. These technologies are key for next-generation data centers powering AI and high-performance computing – accelerating data communications to handle massive information loads with dramatically lower power consumption.  Driven by demand for AI infrastructure, the silicon photonics market is forecasted to surge at nearly 30% annual growth rate (MarketsandMarkets, 2025, Silicon Photonics Market – Global Forecast to 2029). The acquisition of Keystone Photonics, a long-term partner, strengthens FormFactor’s position at the forefront...

Continue reading

Evolve Royalties Ltd. Announces Completion of its Business Combination and Listing on the CSE

Evolve to commence trading on the CSE on December 17, 2025 under the ticker symbol “EVR” Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States. TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) — Evolve Royalties Ltd. (CSE: EVR) (“Evolve” or the “Company”) (formerly Voyageur Minerals Explorers Corp.) is pleased to announce that it has completed its previously-announced business combination (the “Business Combination”) with Evolve Strategic Element Royalties Ltd. and its listing on the Canadian Securities Exchange (“CSE”). Evolve’s common shares (the “Evolve Shares”) are expected to commence trading on the CSE on December 17, 2025 under the symbol “EVR”. The Company’s listing statement is available on its...

Continue reading

Advini and Cordier by InVivo announce their entry into exclusive negotiations to strengthen their position in the French wine industry

Advini and Cordier by InVivo Announce Their Entry into Exclusive Negotiations to Strengthen Their Position in the French Wine Industry Advini Group and Cordier by InVivo announce entry into exclusive negotiations to merge certain activities This merger, sought by both groups, fits perfectly into a strategy of brand, product range, and sales network complementarity. It would allow Advini to strengthen its position in the Bordeaux region with the Cordier brand and enter the sparkling wine market with Café de Paris. Additionally, Advini’s export activities would be enhanced through Cordier’s distribution subsidiaries and presence, in the Netherlands, Belgium, the United States, Canada, South Africa, and Japan. AdVini would benefit from a wider and more diversified portfolio of prestigious brands, as well as a stronger distribution...

Continue reading

Berry Stockholders Approve Combination with CRC

DALLAS, Dec. 15, 2025 (GLOBE NEWSWIRE) — Berry Corporation (bry) (NASDAQ: BRY) (“Berry”) today announced that, at its Special Meeting of Stockholders held earlier today, Berry stockholders voted to approve its combination with California Resources Corporation (“CRC”) (NYSE: CRC). As previously announced, under the terms of the merger agreement, Berry stockholders will receive a fixed exchange ratio of 0.0718 shares of CRC common stock for each share of Berry common stock. According to preliminary results, Berry stockholders approved the transaction with approximately 73% of the total shares outstanding and approximately 98% of the shares voted in support of the combination. The final voting results of Berry’s Special Meeting will be reported in a Form 8-K to be filed with the U.S. Securities and Exchange Commission (the “SEC”). The...

Continue reading

Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline

PARIS, FRANCE, 15 December 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced it has completed the acquisition of ImCheck Therapeutics, a private French biotechnology company pioneering next-generation immuno-oncology therapies. About Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by internal and external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in more than 100 countries. Ipsen is listed in Paris (Euronext: IPN) and in the U.S. through a Sponsored Level I American Depositary Receipt program...

Continue reading

Freshworks to Deepen its IT Service and Operations Portfolio with Acquisition of FireHydrant’s AI-Native Incident Management and Reliability Platform

Freshworks to Deepen its IT Service and Operations Portfolio with Acquisition of FireHydrantFreshworks has signed a definitive agreement to acquire FireHydrant, a provider of AI-powered Incident Management software. The combination will bring together Freshservice’s IT Service Management (ITSM) and FireHydrant’s core IT Operations Management (ITOM) as a unified AI-native ServiceOps solution designed to simplify operations, proactively prevent disruptions, and ensure exceptional IT service reliability.SAN MATEO, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) — Freshworks Inc. (NASDAQ: FRSH) has signed a definitive agreement to acquire FireHydrant, a provider of AI-powered Incident Management software. The combination will bring together Freshservice’s IT Service Management (ITSM) and FireHydrant’s core IT Operations Management...

Continue reading

A&M Capital Acquires Asurint

Greenwich, CT and Cleveland, OH, Dec. 15, 2025 (GLOBE NEWSWIRE) — A&M Capital, a multi-strategy private equity investment firm, and Asurint (the “Company”), an industry-leading provider of background screening solutions, announced today that Asurint has been acquired by A&M Capital Partners (“AMCP”), A&M Capital’s investment strategy focused on middle-market control transactions in North America. Founded in 2005 by Gregg Gay and Connie Clore, Asurint blends advanced technology with human insights to deliver rapid, compliant, and comprehensive background screening results. The Company’s data-driven platform serves leading organizations across the Employment, Tenant, and Government screening sectors. “We are thrilled to partner with the team at A&M Capital as Asurint enters its next era of growth,” said...

Continue reading

GlobalTech Announces D. Boral Capital LLC as Strategic Advisor for Recently Announced Planned Acquisition of Moda in Pelle

RENO, Nev., Dec. 15, 2025 (GLOBE NEWSWIRE) — GlobalTech Corporation (OTC:GLTK) (“GlobalTech”), a U.S. – headquartered technology holding company focused on artificial intelligence (AI), big data, and emerging technologies, today announced that D. Boral Capital LLC (“D. Boral”) is its strategic advisor in connection with the recently announced planned acquisition of 123 Investments Limited d/b/a Moda in Pelle (MIP) and to provide general financial advisory services to the Company related to the acquisition. “We believe D. Boral’s expertise will be instrumental to us as we seek to execute this transaction,” said Dan Green, Chief Executive Officer, GlobalTech. “D. Boral’s track record in supporting high-growth companies aligns well with our ambitions to scale globally, invest in what we believe are cutting-edge solutions, and...

Continue reading

Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

Quipt shareholders to receive US$3.65 per share in cash Transaction provides immediate liquidity and certainty of value to shareholders The per share purchase price represents a 162% premium to Quipt’s unaffected stock price on May 19, 2025, the last full trading day prior to the public disclosure of Forager’s $3.10 per share proposal, and a 54% premium to Quipt’s 30-day VWAP as of December 12, 2025CINCINNATI, Dec. 15, 2025 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it has entered into a definitive agreement (the “Arrangement Agreement”) pursuant to which a special purpose acquisition vehicle (the “Purchaser”), to be funded by affiliates of each of Kingswood Capital...

Continue reading

Schouw & Co. share buy-back programme, week 50 2025

On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 120 million during the period 5 May to 31 December 2025. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount    Accumulated until 5 December 2025 198,400 597.72 118,588,339    Monday, 8 December 2025 400 613.92 245,568    Tuesday, 9 December 2025 500 615.09 307,545    Wednesday, 10 December 2025 500 618.99 309,495    Thursday, 11 December 2025 500 617.69 308,845    Friday,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.